# Why is the PCR amplification efficiency still ignored?

> The delta delta Ct method of Livak and Schmittgen assumes equal PCR efficiencies of 100%, and most papers never check it. Why it is still ignored, and what it costs.

Source: https://clarida.bio/blog/pcr-amplification-efficiency
Updated: 2026-10-30

[Blog](https://clarida.bio/blog)

Most qPCR results assume 100% amplification efficiency. When that assumption is wrong, the published fold differences are wrong too. Here is why the actual efficiency cannot be ignored.

By [J.M. Ruijter](https://clarida.bio/blog/pcr-amplification-efficiency#about-the-authors)

September 12, 2016 Updated October 30, 2026 4 min read

First published on [the qbase+ website](https://web.archive.org/web/20190131061426/https://blog.qbaseplus.com/why-is-the-pcr-amplification-efficiency-still-ignored). On Clarida since February 7, 2026, with minor edits for readability.

Most quantitative PCR (qPCR) results in journals are nowadays presented as Ct, delta Ct (dCt) or delta delta Ct (ddCt) values. Often the correct interpretation of the Y-axis in graphs has to be derived from the numbers given, which are not always in line with the axis title. This title most probably indicates that the axis represents the fold difference of the normalized expression of the target gene between the experimental and control conditions. It is of note that by now the 2 and the minus sign that should be there to turn a delta delta Ct into such a fold-difference have disappeared almost completely from publications. This tendency to avoid formulas has turned quantitative PCR into a field of meaningless numbers. For references to illustrate this, just google [delta delta Ct](https://www.google.com/search?q=delta+delta+ct).

## The assumption nobody checks

Although this situation gives the impression that delta delta Ct needs no explanation for the users of qPCR, the opposite is true. Seemingly the presence of asterisks (to denote statistical significance) in the graphs satisfies the reviewer and the reader and thus abolishes the need for further understanding; the results are significant whatever they are. Without knowing, the reader has assumed that the amplification efficiencies of both target of interest and reference gene were all equal to 2, which means a doubling per PCR cycle or a 100% efficient assay. However, from the onset of qPCR, the authors in the field have highlighted that dCt and ddCt cannot be applied when there is a difference in amplification efficiency of the target and reference genes being compared.

The $2^{-\Delta\Delta C_t}$ equation for relative quantification that is referred to in most publications was originally accompanied by a procedure to check that the amplification efficiencies of the target and reference genes were sufficiently similar ([Livak and Schmittgen, 2001](https://pubmed.ncbi.nlm.nih.gov/11846609/)). However, within a few years of qPCR it was clear that the implicit assumption of this equation that all PCR assays were 100% efficient was wrong and an alternative equation for efficiency corrected relative quantification was published ([Pfaffl, 2001](https://pubmed.ncbi.nlm.nih.gov/11328886/)). The required PCR efficiency could be derived from a dilution series. When such dilution series are dutifully performed, the linearity of the Ct against log(input) is checked and, if confirmed, the resulting PCR efficiencies are quietly forgotten. Indeed, my experience is that in qPCR courses, less than 50% of the participants is aware of the role of the amplification efficiency in PCR.

## The math behind the problem

Equation alert: skip the next paragraph when you are allergic to equations. However, reading this paragraph will make it easier to understand why the amplification efficiency cannot be ignored.

As the MIQE guidelines ([Bustin et al., Clinical Chemistry, 2009](https://pubmed.ncbi.nlm.nih.gov/19246619/)) propose to use quantification cycle ($C_q$) over threshold cycle ($C_t$) and other terms referring to the same value from the real-time instrument, I will be using $C_q$ for the remainder of this post.

Whereas the original paper on efficiency corrected relative quantification ([Pfaffl, 2001](https://pubmed.ncbi.nlm.nih.gov/11328886/)) attempted to stay close to the original $\Delta\Delta C_q$ equation, the realization that multiple reference genes were required ([Vandesompele et al., 2002](https://pubmed.ncbi.nlm.nih.gov/12184808/)) necessitated the developers of qPCR analysis software to go back to the original kinetic equation of the PCR reaction ($N_C = N_0 \cdot E^C$). The target quantity $N_0$ can be directly derived from inversion of this equation and the definition of $C_q$. Because $C_q$ is the number of cycles needed to reach a threshold $N_q$, the inversion of the kinetic equation shows that $N_0 = N_q / E^{C_q}$ ([Ruijter et al., 2009](https://pubmed.ncbi.nlm.nih.gov/19237396/)).

When the $C_q$ is derived for a target gene (with efficiency $E_T$) and for a reference gene ($E_R$), for control and treated conditions, the relative gene expression (target/reference for treated/control) can be calculated as:

$$
Fold = \frac{E_R^{\,(C_{q,R,Tr} - C_{q,R,C})}}{E_T^{\,(C_{q,T,Tr} - C_{q,T,C})}}
$$

\[Eq. 1\]

## The simplification that causes the bias

With the assumption that both efficiencies are 2 and a rearrangement of the $C_q$ values in the exponent, this equation simplifies to the full write-out of the $2^{-\Delta\Delta C_q}$ equation:

$$
Fold = 2^{-\left((C_{q,T,Tr} - C_{q,R,Tr}) - (C_{q,T,C} - C_{q,R,C})\right)}
$$

\[Eq. 2\]

## What happens in practice

The effect of this simplifying assumption is illustrated with four target genes and a reference gene in an experiment with three treatments and a control condition. The target genes all have the same expression level but show a three-fold increase between the control and each of the treatments; the expression level of the reference gene is constant in all conditions. Note that each target is amplified with another efficiency.

Target 1, amplified with an efficiency of 2, shows the correct fold difference in each of the treatments, regardless whether \[Eq. 1\] or \[Eq. 2\] is used for the calculation. For treatment 1, with only a 3-fold difference compared to the control, the use of \[Eq. 2\] results in only slightly deviating values, even when the efficiency value of the target is far below 2. However, with increasing effect of the treatment and decreasing PCR efficiency of the targets the bias caused by \[Eq. 2\] becomes increasingly clear.

Given the sensitivity of qPCR, with enough biological replicates the use of the $\Delta\Delta C_q$ equation will lead to the conclusion that the targets are differentially expressed in treatments 2 and 3. This obviously wrong conclusion illustrates why the actual PCR efficiencies have to be included in the calculation of qPCR results.

## Why efficiency is still ignored

But what is the reason that PCR efficiencies of the targets and references are often ignored and implicitly considered to be 2? Probably because most researchers, reviewers and readers think that in relative quantification the efficiency differences disappear from the calculation. The example shows that is not the case. It shows what can happen to the published results when PCR assays are not 100% efficient.

## Key takeaways

- The delta delta Cq method assumes all amplification efficiencies equal 2 (100% efficient). This assumption is often wrong.
- When target and reference genes have different efficiencies, the uncorrected equation produces biased fold differences.
- The bias grows with larger expression differences and lower PCR efficiencies, potentially leading to wrong conclusions.
- Efficiency-corrected relative quantification (Eq. 1) uses the actual efficiency values and eliminates this bias.
- Always include the measured PCR amplification efficiency in your calculations, even when the dilution series looks linear.

## About the author

- J.M. Ruijter

  Retired Principal Investigator, AMC Amsterdam

  Developed methods for 3D analysis and visualization of gene expression patterns during embryogenesis and for the analysis of quantitative PCR data. Creator of [LinRegPCR](https://pmc.ncbi.nlm.nih.gov/articles/PMC8386043/), a widely used method for assumption-free estimation of PCR amplification efficiency.

  [ResearchGate](https://www.researchgate.net/scientific-contributions/Jan-M-Ruijter-39448570)

## See the efficiency behind each result.

Clarida uses each assay's efficiency in your quantification and names its source for every target.

[Start free](https://app.clarida.bio/login) · [See how it works](https://clarida.bio/training/qpcr-workflow-tutorial)
